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S U M M A R Y
Background: Rabies viral infection causes a fatal encephalomyelitis. In humans, classic features include
hydrophobia, aerophobia, hypersalivation, agitation, and neurological symptoms. In the Philippines,
canine rabies contributes to a signiﬁcant burden of human disease.
Methods: We retrospectively reviewed the medical records of 1839 patients admitted to San Lazaro
Hospital, Manila, Philippines between 1987 and 2006, with a clinical diagnosis of rabies. We used the
World Health Organization case deﬁnition for clinical rabies, which is deﬁned by the presence of
hydrophobia.
Results: Male patients outnumbered females by 2.2 to 1 and twice the number of adults were affected
compared with children. Most patients were indigent. Dog bites occurred more than cat bites (97.1% vs.
2.9%) and most cases were caused by a single bite (86.2%), compared to multiple bites (8.7%). Bites to the
face, head, and neck led to shorter incubation times, yet the incubation period varied, with most cases
(42.7%) occurring in the bracket of 91–365 days post-exposure. Clinical symptoms included hydrophobia
in all cases, as per our case deﬁnition, and aerophobia in 95.5%; only 9.4% had fever, 9.2% exhibited
restlessness, and 6.7% exhibited hypersalivation. Localized neurological symptoms included pain (4.1%),
numbness (2.6%), and itching (2.3%). None of the patients received appropriate post-exposure
prophylaxis (PEP).
Conclusions: This study examines the largest cohort of rabies patients reported to-date. Better
understanding of clinical disease manifestations may help in salvage efforts to save patients with rabies.
Knowledge of epidemiological factors will improve preventative efforts to reduce suffering from rabies.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Rabies threatens millions of people in developing countries.
Tens of thousands of victims die each year, despite it being a
vaccine-preventable disease.1 There are no universally accepted
effective treatments for rabies once clinical symptoms are
manifest.
Rabies is an encephalomyelitis of mammals marked by certain
distinctive features. In humans, symptoms often include hydro-
phobia, hypersalivation, and neurological manifestations such as
paresthesias. However, signiﬁcant variability in disease presenta-
tion may occur. In developed countries, most clinical reports of
human rabies are conﬁned to one case.2 Comparisons among these
cases often reveals varied symptoms. Failure to recognize rabies in
the USA and Europe has led to disastrous consequences in organ
transplantation.3,4 Further, the survival of a teenager in the USA* Corresponding author. Tel.: +1 203 709 6402; fax: +1 203 709 3049.
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doi:10.1016/j.ijid.2011.03.023who underwent an unorthodox treatment, dubbed the ‘Milwaukee
protocol’, has renewed interest in rabies symptomatology and
pathophysiology.5–7 Claims of salvaging other rabies patients with
intensive treatment protocols has ignited ﬁerce debate among
rabies experts.8–11 Some authorities advocate aggressive treat-
ment in the hopes for a cure, while others believe treatment is
futile and palliative care should be the primary focus. Further
clinical understanding of rabies may lead to new ideas for
treatment and possibly prevent death. The purpose of this study
was to describe the largest cohort of cases ever reported in an effort
to better understand this enigmatic disease.
Rabies is caused by infection with any of the members of the
Lyssavirus genus, of which the rabies virus comprises genotype 1.
There are a number of other lyssaviruses known to cause the
clinical symptoms of rabies.12,13 Dog rabies viral strains predomi-
nate in most of the developing world including Asia and Africa.14 In
the Philippines, almost all cases of human rabies occur from dog-
related injuries including bites and scratches.15 Rabies in North
America is a zoonotic disease, largely associated with bats and wild
carnivores. Canine rabies in the USA has been declared eliminatedses. Published by Elsevier Ltd. All rights reserved.
Table 1
Rabies cases according to type of exposure and clinical manifestations, N = 1839
No. of cases (%)
Type of exposure
Bite exposure 1814 (98.6)
Single bite 1563 (86.2)
Face, head, and neck 285 (15.7)
Fingers 223 (12.3)
Upper extremities 397 (21.9)
Lower extremities 583 (32.1)
Others (buttocks, back, chest, genitalia, etc.) 75 (4.1)
Multiple 158 (8.7)
Unknown bite site 93 (5.1)
Non-bite exposure 25 (1.4)
Eating raw dog meat 21 (84)
Unknown 4 (16)
Clinical manifestations
Hydrophobiaa 1839 (100)
Aerophobia 1756 (95.5)
Fever 173 (9.4)
Restlessness 169 (9.2)
Hypersalivation 124 (6.7)
Behavioral changes (agitation, aggressiveness, irritability) 123 (6.7)
Nausea/vomiting 119 (6.5)
Chest pain 115 (6.3)
Incoherence 108 (5.9)
Urinary frequency 87 (4.7)
Dysuria 83 (4.5)
Bite site pain 76 (4.1)
Paralysis/paresis 71 (3.9)
Numbness of bite site 48 (2.6)
Itchiness of bite site 43 (2.3)
Other:
Photophobia 24 (1.3)
Epigastric pain 15 (0.8)
Upward rolling of eyeballs/nystagmus 8 (0.4)
Facial palsy/asymmetry 2 (0.1)
a Case deﬁnition included hydrophobia.
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decades ago.16 Unfortunately, rabies in wildlife continues to thrive
because of complicated factors.17 Bat exposures comprise the
majority of cases of human transmission in the last four decades.
Imported cases in immigrants and travelers visiting endemic areas
make up the remainder.18 Typically one or two cases are
recognized in the USA per year, although the true burden of
disease is unknown and is the subject of investigation.19 Almost
half of cases are diagnosed post-mortem, probably because bat-
exposures are underreported and/or not recognized as danger-
ous.18 In countries where the overall case load is low, recognition
of the disease can be difﬁcult.
Rabies is insidious with a variable asymptomatic period
following inoculation and incubation. Past clinical descriptions
cite an incubation period of 1 to 3 months, with a range of 4 days
to 19 years.20 It is understood that shorter incubation times
often correlate with severe bite exposures to the head and neck.
Longer incubation times, particularly those greater than 1 year,
are less common. Although it is possible that ‘unrecognized’ re-
exposure may account for some of the cases described with long
incubation periods, the US Centers for Disease Control and
Prevention (CDC) has documented cases in US immigrants with
rabies strains unique to their country of origin, with years of
latency.21
The prodromal symptoms of rabies are typically ‘nonspeciﬁc’
and frequently not recognized by practicing clinicians. Often there
is a delay in diagnosis. The majority of rabies cases are of the classic
encephalitic or ‘furious’ form, while a progressive paralytic illness
has also been described. Reports suggest that in classic rabies,
hydrophobia can be demonstrated in 50–80% of cases.18,22
Aerophobia is described as a prominent symptom and can be
elicited by the ‘fan test’.23 Agitation alternating with calm is
another prominent feature of furious type cases as well.24 Local
sensory symptoms such as paresthesias or itching occur in as many
as 30% of both furious and paralytic patients.22 Progression
through various stages, including confusion, coma, and death
occurs in virtually 100% of cases. Patients with furious disease die
earlier on average (5 days) than those with the paralytic form (13
days).22,24–26 Cases of paralytic or ‘dumb’ rabies are the most
challenging. Hydrophobia and hypersalivation, for example,
appear late in the disease course and are usually mild.22 The
diverse clinical features of each rabies case may relate to different
viral tropisms, routes of neural spread, different sites of neural
involvement, variable immune responses, and/or other pathologic
mechanisms.24,27,28 We thought it of value to review our clinical
experiences with rabies cases in this context.
2. Methods
Our institution, San Lazaro Hospital, is an urban 500-bed
hospital serving as the national referral center in the Philippines
for infectious diseases. We treat approximately one quarter to one
third of the human rabies cases reported for the country each year.
A retrospective chart review of all patients identiﬁed as having
clinical rabies was conducted for the time-period January 1987
through June 2006. Cases were classiﬁed as rabies if the symptom
of hydrophobia was elicited, as this symptom is an unmistakable,
unique, and startling feature of rabies illness. Patients were also
subjected to a fan test to examine for aerophobia. These signs are
supported by the World Health Organization as compatible with
human rabies.29 Almost all cases of human rabies in developing
countries are diagnosed this way. Patient signs and symptoms
were recorded at the time of diagnosis in the emergency
department. The patients were then transferred to the rabies
ward. In general, no serological, virological, or other laboratory
tests were performed. We reviewed the medical records of thesepatients utilizing a standard form to extract patient data. The
results are summarized here.
3. Results
During the review period of 19.5 years, a total of 1839 rabies
cases were admitted. All patients died and most had an obvious
history of an animal bite or scratch. Cases per year ranged from a
low of 57 to a high of 119. On average, 92 cases were admitted per
year. There was a strong predilection for male patients, who
outnumbered females in a ratio of 2.2:1. Adults outnumbered
children (classiﬁed as less than age 20) by a ratio of 2 to 1. The
youngest rabies patient was 2 years old and the oldest was 89 years
old. Just over half (51.4%) of the cases were classiﬁed as
‘unemployed’, while students made up almost 20% of cases
(n = 367). Almost all patients were from indigent sectors of society
(n = 1831). Four hundred and thirty-nine or 23.9% of our rabies
cases came from Manila. Nearby provinces contributed the
majority of other cases.
Animal bites comprised the majority of exposures (n = 1814;
98.6%), with 86.2% of cases attributable to a single bite (n = 1563)
(Table 1). Multiple bites accounted for 8.7% (n = 158) of those cases
with a bite exposure history. The location of bites mostly involved
the upper extremities (n = 397) and ﬁngers (n = 223), which
combined accounted for 34.1% of bite exposures, whereas the
lower extremities comprised 32.1% (n = 583). Face, head, and neck
bites accounted for 15.7% of bite exposures (n = 285). Non-bite
exposures accounted for 1.4% of cases (n = 25), the majority of
which were ascribed to eating raw dog meat (n = 21). Four of the
non-bite exposures had no recognized exposure whatsoever (0.2%
of the total). There was no information collected about bat
exposures.
Table 2
Estimated incubation perioda (days) per bite site
Bite site <7 (%) 8–14 (%) 15–21 (%) 22–30 (%) 31–90 (%) 91–365 (%) >365 (%)
Face, head, neck 5 (0.3) 32 (1.8) 49 (2.8) 57 (3.3) 84 (4.8) 46 (2.6) 12 (0.7)
Fingers 0 0 13 (0.7) 21 (1.2) 44 (2.5) 106 (6.1) 39 (2.2)
Upper extremities 0 0 3 (0.2) 8 (0.5) 76 (4.4) 225 (12.9) 85 (4.9)
Lower extremities 0 0 0 5 (0.3) 58 (3.3) 369 (21.2) 151 (8.7)
Other sites (buttocks, back, chest, genitalia) 0 0 1 (0.1) 6 (0.3) 23 (1.3) 31 (1.8) 14 (0.8)
Multiple bite 2 (0.1) 5 (0.3) 16 (0.9) 24 (1.4) 69 (4.0) 34 (2.0) 8 (0.5)
Non-bite (eating raw dog meat) 0 0 0 3 (0.2) 7 (0.4) 11 (0.6) 0
Total casesb 7 (0.4) 38 (2.1) 92 (5.0) 155 (8.4) 498 (27.1) 785 (42.8) 251 (13.7)
a Time of exposure to the time of manifest signs and symptoms; eight cases were of 5 years incubation (0.4%) and one case was of 27 years incubation (0.1%).
b Not all bite locations were recorded, thus n = 1835 for total cases and n = 1742 for all cases for which a bite location was recorded.
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exposure to clinical onset of disease varied, with the greatest
number of cases occurring in the 91–365-days post-exposure
category (n = 785 or 42.8%) (Table 2). The second most common
group was the 31–90-days cohort with 498 cases (27.1%). Two
hundred and sixty cases (14.1%) had an incubation period of more
than 1 year, with eight cases (0.4%) occurring at 5 years post-
exposure. Our longest reported incubation time was 27 years
following a dog bite vaguely recalled by the patient’s relatives.
Short incubation times were also observed, with seven cases
occurring within 1 week of recognized exposure (0.4%). Two
hundred and ninety-two cases occurred within 1 month of
exposure (15.9%). Face, head, and neck bites appeared to have
shorter incubation times compared with bites to the extremities
(Table 2). Finger bites and upper extremity bites tended to have
shorter incubation periods compared with lower extremity bites.
Multiple bites in general led to shorter incubation times as well.
With regard to the biting animals, dog bites 97.1% (n = 1638)
outnumbered cat bites 2.9% (n = 49). Most dogs were considered
‘stray’ (64.5%; n = 1057), while 35.5% (n = 581) were unvaccinated
domesticated pet dogs.
Ninety-two percent of the patients did not seek a proper
medical consultation. Just more than half sought a consultation
with local non-physicians (‘tandoks’ or faith healers) who are
commonly entrusted with minor health problems at the local level.
Only 7.4% of patients sought a true medical consultation following
exposure and the remainder did not seek aid. Of those receiving a
medical evaluation, only 31 (22.5%) took post-exposure prophy-
laxis (PEP), largely for cost reasons. Among these patients, 25.8%
received rabies immune globulin (RIG) and an incomplete
vaccination series up to 7 days after the bite; only one patient
received the complete vaccination series but experienced a 2-day
treatment delay in receiving RIG. Additionally, this patient had
multiple facial bites and RIG was given intramuscularly rather than
around the bite wounds. Twenty-two (15.9%) patients received
anti-rabies vaccination (ARV) without passive immunization.
We tabulated the clinical symptoms recorded on admission for
our patients (Table 1). All cases were deﬁned as rabies based on the
presence of hydrophobia elicited upon admission. The fan test was
also used to elicit aerophobia, which occurred in 95.5% (n = 1756).
Other symptoms appeared less prominent, including fever (9.4%),
restlessness (9.2%), and hypersalivation (6.7%). Various neuro-
pathic symptoms localized to the bite site consisted of pain (4.1%),
numbness (2.6%), and itchiness (2.3%). Photophobia was noted in
1.3% of cases. Interestingly chest pain (found in 6.3%) and other
symptoms not immediately suggestive of rabies led to an initial
misdiagnosis in 61 cases (3.3% of the total).
4. Discussion
This retrospective review of 1839 rabies cases admitted to our
institution in the past 19.5 years is the largest case series reported.Our data show longer incubation times, on average, than previous
studies.30,31 This relates to various factors including location and
type of bite wound(s), inoculum and immediate wound treatment,
possibly viral strains, and host factors. Additionally, we report the
longest known incubation time of 27 years, which surpasses the
previous record of 19 years.20 This history relied on patient
relatives and it is possible that a forgotten more recent exposure
had occurred.
We noted a distinct correlation between bite site and
incubation period, with face, head, and neck bites having the
shortest incubation times. Other studies have also demonstrated
this phenomenon.32 Our data highlight the importance of
obtaining expedient medical treatment for these bites. Interest-
ingly, eating raw dog meat appeared to have a small but
recognizable rabies risk. Rabies cases due to the slaughtering,
preparation, and consumption of street animals (dog and cat) have
been reported.33
These data show a high predominance of canine-related rabies.
Although we did not perform viral testing (PCR), we presume cases
were dog virus variants native to the Philippines. It is unknown
how these dog strains might cause different disease manifestations
relative to other dog rabies variants (i.e., from India, Thailand, etc.)
or other animal strains such as bat variants. Bat-associated viruses
may exhibit more of a clinical difference in human hosts, but this
has not been evaluated fully and remains unclear. There were no
documented ‘bat exposures’ in our series and a thorough
evaluation of potential wildlife rabies reservoirs in the Philippines
has not been undertaken.
We were surprised at the relatively low percentages of rabies
signs and symptoms that are classically described, such as
hypersalivation, fever, and localized neurological phenomena.
Whether this relates to reporting bias is unclear. Hemachudha
reports fever as a constant ﬁnding in all cases, usually more
pronounced later in the disease course.24 Among North American
cases, more than 80% reported fever as a clinical ﬁnding.2 We note
that each case of rabies can manifest differently, and the astute
clinician should be wary of suspicious signs and symptoms,
particularly when a suspect animal exposure history is obtained.
We noted that the majority of our patients were from lower
socioeconomic groups who lacked knowledge, resources, or both,
which compromised their access to appropriate medical care.
Belief in the local faith-healers and scarce access to properly
trained medical professionals often led to fatal illness. Male
patients outnumbered female cases likely because of cultural
factors associated with exposures. A good number of clinical
‘failures’ resulted from improper management relating to cost of
treatment. RIG is relatively expensive and omissions or delays in
administration certainly caused some deaths. Endemic countries
wishing to decrease the burden of human rabies should seek to
limit such barriers to life-saving treatment.
Our data were unable to deﬁne whether rabies in the
Philippines is more of a rural versus urban disease. Although
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quarter of cases derived from Manila, a metropolis estimated to
comprise over 14 million people.
Although we lacked conﬁrmatory serologic, virologic, and other
laboratory testing methods, the presence of hydrophobia in a
highly endemic area with features of a rapidly fatal encephalopa-
thy allowed us to classify these cases as rabies. No other disease
manifests hydrophobia except for rabies hysteria, which is non-
fatal. Our clinicians have excellent experience with tetanus cases,
and other differential diagnoses seemed remote. Additionally, a
high proportion of patients exhibited aerophobia, another
pathognomonic sign of rabies.
Other cases of rabies were possibly missed, as not all cases of
rabies exhibit hydrophobia, and paralytic disease may lack this
feature. Since hydrophobia was key to our clinical diagnoses, we
estimate the regional rabies burden could be 10–50% higher than
what our review captured. Comparison of clinical cases in this
review therefore has a limitation to those patients with clearly
recognizable hydrophobia. Diagnosis of all the clinical rabies cases
occurring in developing and developed countries remains a
challenge. However, because of our large sample size, we believe
this does not meaningfully affect our results.
This study was subject to other limitations. Because it was
retrospective, reporting biases undoubtedly occurred. Historical
recollections depended almost entirely on patient family mem-
bers, which may have led to inaccuracies in recall. We were unable
to evaluate the quality of the historical reporting in this
retrospective review. A prospective study may better be able to
gauge the value of historical information through a grading system.
For example, more value could be attributed to a history from a
lucid patient compared with information provided by a relative of a
comatose patient.
Many physicians contributed to the collection of data and
therefore some intra-observer variations probably occurred.
Physical examinations tended to be brief, without full neurological
evaluation for every case. Whether this explains the relatively low
percentages of other signs and symptoms is unclear. A more
rigorous prospective study could be designed to speciﬁcally
examine for some of these described rabies features.
Finally, this study only analyzed symptoms recorded on
presentation to the hospital, as typically no signiﬁcant further
physician–patient interactions took place following the rabies
diagnosis. (Patient care was continued on a specialized rabies ward
with dedicated nursing personnel who administered medications
for comfort. San Lazaro hospital’s standard operating procedures
(SOP) on the management of rabies require treatment with ‘‘heavy
sedation of patients to relieve their pain and terror’’. Relatives who
opted to bring their patients home to die were advised to receive
post-exposure prophylaxis based on exposure risk.) Full clinical
follow-up for the length of hospital admission would undoubtedly
reveal more useful information. Of course laboratory and other
technical studies of rabies patients from admission through their
hospital course would also be worthwhile, yet remains difﬁcult to
accomplish in resource-constrained areas where many rabies cases
occur. We did not have facilities for storage of these viral isolates,
so no molecular or phylogenetic analyses could subsequently be
performed.
We believe this review furthers understanding of human rabies.
Knowledge of exposure risks as well as presenting signs and
symptoms may increase diagnoses in countries of low prevalence,
possibly limiting morbidity and mortality. Preventative efforts to
relieve rabies suffering in highly endemic areas should continue in
earnest, with a focus on indigent populations. Prospective studies
would yield more useful details regarding the disease in many
aspects. Renewed efforts at the treatment of rabies should begin
with a solid understanding of the disease itself.Acknowledgements
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